Neuroscience

Articles and news from the latest research reports.

63 notes

An immunosuppressive drug could delay the onset of neurodegenerative diseases

Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This is the main conclusion of a study published in the Nature in which has collaborated the researcher Isidro Ferrer, head of the group of Neuropathology at the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital and Full Professor of Pathological Anatomy at the University of Barcelona. The research was led by researchers from the International School for Advanced Studies (SISSA) in Trieste (Italy).

The collaboration of the research group led by Dr. Ferrer with SISSA researchers began five years ago when they observed that Parkinson’s patients showed a deficit in UCHL1 protein. At that time, researchers didn’t know what mechanism produced this deficit. To discover it a European project was launched. It was coordinated by the Italian researchers and participated by other European research groups, including the group led by Dr. Ferrer. The project, called Dopaminet, focused on how dopaminergic neurons (brain cells whose neurotransmitter is dopamine) are involved in Parkinson’s disease.

Contrary to most common hypothesis that a DNA fragment encodes a protein through a messenger RNA molecule, the researchers found that it also works in reverse. They found a balance between the protein and its mirror protein, which is configured in reverse, and they are mutually controlled. If the protein mirror is located in the nucleus of the cell, it does not interact with the protein, while if it is in the cytoplasm, then both of them interact.

In the case of Parkinson’s disease the protein UCHL1 appears reduced and also its mirror protein is localized in the nucleus, and in the cytoplasm. Thus, the researchers sought a method to extract the mirror protein from the nucleus and made it interact with the original UCHL1 protein. The authors found that rapamycin was able to extract them from the nucleus. The drug allows the two proteins, the UCHL1 and its mirror, hold together in the cytoplasm, which would correct the mistakes that occur in Parkinson’s disease.

This in vitro research has allowed describing a new unknown mechanism. It is necessary that the UCHL1 mirror protein should accumulate in the nucleus and escape from the cytoplasm and join the UCLH1 protein. The combination of both makes the system work.

"The rapamycin can not cure Parkinson’s disease, but it may delay the onset of neurodegenerative diseases such as Alzheimer’s and Parkinson’s itself. Rapamycin can protect and delay the beginning of these diseases. It can complete the treatment, but it should be combined with other existing treatments", explains Isidro Ferrer.

Anyway, it is still far its application in patients. The next step is to validate these results in animal models and study the effects of rapamycin in combination with other drugs.

(Source: idibell.cat)

Filed under neurodegenerative diseases brain cells cytoplasm neurotransmitter transplants neuroscience science

  1. w-bnews reblogged this from neurosciencestuff
  2. brainstufffyi4dew0319 reblogged this from scientificthought
  3. jenericalname reblogged this from neurosciencestuff
  4. dundermifflin1nc reblogged this from sleeplessinstinct
  5. reinkaosophia reblogged this from sleeplessinstinct
  6. sleeplessinstinct reblogged this from neurosciencestuff
  7. incapableofgivingup reblogged this from neurosciencestuff
  8. alexdotexe reblogged this from neurosciencestuff
  9. marvel-is-ruining-my-life reblogged this from neurosciencestuff
  10. futurenow321 reblogged this from neurosciencestuff
  11. george-allan reblogged this from neurosciencestuff
  12. erikisamazing reblogged this from neurosciencestuff
  13. quivertech reblogged this from neurosciencestuff and added:
    Interesting research that might be able to help someone I know.
  14. astroghoul reblogged this from scientificthought
  15. stephaniemyer reblogged this from neurosciencestuff
  16. uberthescout reblogged this from neurosciencestuff
  17. jacquieplz reblogged this from neurosciencestuff
  18. theme27fp reblogged this from reciitando
  19. alsadvocate reblogged this from neurosciencestuff
  20. science-and-logic reblogged this from neurosciencestuff
  21. questionall reblogged this from neurosciencestuff
  22. climbinglyell reblogged this from neurosciencestuff
  23. thuglifejay reblogged this from neurosciencestuff
  24. comfortableanddangerous reblogged this from neurosciencestuff
  25. mkfour reblogged this from neurosciencestuff
  26. barroomhero reblogged this from neurosciencestuff
free counters